Furthermore, the paper indicated that standard MyPlate guidance, typically based on a 2,000-calorie diet, may not be tailored for the lower caloric needs or specific nutritional challenges of individuals on GLP-1RA therapy
Fifth, significantly lower incidence of proliferative DR and composite surgical outcome were observed in SGLT2i users than GLP1 users in all subgroup analysis, which strengthen the power of evidence in this study
This doesn't mean high-concentration products are dangerous or ineffective
Layer P, Peschel S, Schlesinger T, and Goebell H
PMID 4195988
(10) Tesamorelin & Ipamorelin Blend and Type 2 Diabetes Preclinical and clinical studies have suggested that both Tesamorelin and Ipamorelin hold promise in improving glycemic control and mitigating the metabolic abnormalities associated with T2DM